​​​​​​​Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Preliminary Results
25.02.2020 / 11:26
The issuer is solely responsible for the content of this announcement.

Berlin, 25 February 2020. The Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, SDAX), achieved sales of just under 180 million EUR and earnings per share of 4.29 EUR in fiscal year 2019 according to preliminary, unaudited calculations. Without the one-off effects forecasted on November 12, earnings per share would have amounted to around EUR 4.60.

The complete and audited financial statements for 2019 and the forecast for 2020 will be published on 31 March 2020.

About Eckert & Ziegler.
Eckert & Ziegler Eckert & Ziegler Strahlen- und Medizintechnik AG with more than 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the SDAX index of Deutsche Börse.
Contributing to saving lives.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de

25.02.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de